A 26-WEEK STUDY OF EFFICACY AND SAFETY OF DELAYED-RELEASE PREDNISONE IN NEWLY DIAGNOSED CASES OF GIANT CELL ARTERITIS: AN INTERIM ANALYSIS

被引：0
|
作者：
Raine, Charles [1 ]
Maw, Win [1 ]
Williams, Mark [1 ]
Gayford, Dawn [1 ]
Mapplebeck, Sarah [1 ]
Mackerness, Craig [1 ]
Dasgupta, Bhaskar [1 ]
机构：
[1] Southend Univ Hosp NHS Fdn Trust, Dept Rheumatol, Westcliff On Sea, Essex, England
来源：
RHEUMATOLOGY | 2014年 / 53卷
关键词：
TEMPORAL ARTERITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页码：7 / 8
页数：4
相关论文
共 50 条
  • [41] Efficacy and safety of Nilotinib in routine clinical management of newly diagnosed Ph plus CML patients in chronic phase-3rd interim analysis of the non-interventional MOMENT II-study
    Lathan, B.
    Sauer, A.
    Ulshoefer, T.
    Lange, E.
    Tebbe, S.
    Schulze, M.
    Janssen, J.
    Meincke, M.
    Frank, O.
    Tesch, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 115 - 116
  • [42] DIAGNOSTIC PERFORMANCE OF PET/CT IN PATIENTS WITH NEWLY DIAGNOSED, BIOPSY-PROVEN, GIANT-CELL ARTERITIS. A PROSPECTIVE, CASE-CONTROL STUDY USING ROC ANALYSIS AT DIFFERENT VASCULAR TERRITORIES
    Prieto-Gonzalez, S.
    Depetris, M.
    Garcia-Martinez, A.
    Espigol-Frigole, G.
    Planas-Rigol, E.
    Corbera-Bellalta, M.
    Tavera-Bahillo, I.
    Butjosa, M.
    Alba, M. A.
    Grau, J. M.
    Hernandez-Rodriguez, J.
    Lomena, F.
    Cid, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 122 - 122
  • [43] Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study
    Fukasawa, Satoshi
    Suzuki, Hiroyoshi
    Kawaguchi, Kazushiro
    Noguchi, Hidehisa
    Enjo, Kentaro
    Tran, Namphuong
    Todd, Mary
    Fizazi, Karim
    Matsubara, Nobuaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (11) : 1012 - 1021
  • [44] Prevalence of Newly Diagnosed Malignancies in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis, Comparison of 18F-FDG PET/CT Scan with Chest X-ray and Abdominal Ultrasound: Data from a 40 Week Prospective, Exploratory, Single Centre Study
    Emamifar, Amir
    Hess, Soren
    Ellingsen, Torkell
    Kay, Susan Due
    Bang, Jacob Christian
    Gerke, Oke
    Hansen, Per Syrak
    Farahani, Ziba Ahangarani
    Petersen, Henrik
    Marcussen, Niels
    Hansen, Inger Marie Jensen
    Ronn, Peter Thye
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (12) : 1 - 13
  • [45] Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study
    Suzuki, Hiroyoshi
    Shin, Toshitaka
    Fukasawa, Satoshi
    Hashine, Katsuyoshi
    Kitani, Sumiko
    Ohtake, Noriyuki
    Shibayama, Kazuhiro
    Tran, Namphuong
    Mundle, Suneel
    Fizazi, Karim
    Matsubara, Nobuaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (07) : 810 - 820
  • [46] Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study
    Drach, Johannes
    Huang, Huiqiang
    Samoilova, Olga
    Belch, Andrew
    Farber, Charles
    Bosly, Andre
    Novak, Jan
    Zaucha, Jan
    Dascalescu, Angela
    Bunworasate, Udomsak
    Masliak, Zvenyslava
    Vilchevskaya, Kateryna
    Robak, Tadeusz
    Pei, Lixia
    Rooney, Brendan
    de Velde, Helgi van
    Cavalli, Franco
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 896 - 903
  • [47] Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study
    Ginsberg, Y.
    Arngrim, T.
    Philipsen, A.
    Gandhi, P.
    Chen, C. -W.
    Kumar, V.
    Huss, M.
    CNS DRUGS, 2014, 28 (10) : 951 - 962
  • [48] Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study
    Y. Ginsberg
    T. Arngrim
    A. Philipsen
    P. Gandhi
    C.-W. Chen
    V. Kumar
    M. Huss
    CNS Drugs, 2014, 28 : 951 - 962
  • [49] NOVEL-1st: Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph plus ) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan
    Wen-Li, Hwang
    Han, Shao-Min
    Lin, Shyuann-Yuh
    Chang, Ming-Chih
    Bai, Li-Yuan
    Hsiao, Pei-Ching
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Liu, Ta-Chih
    Wang, Po-Nan
    Gau, Jyh-Pyng
    Lee, Yee-Ming
    Ku, Fan-Chen
    Tang, Jih-Luh
    BLOOD, 2020, 136
  • [50] NOVEL-1st: Interim Analysis of a Non-Interventional, Multi-Center Observational Study to Assess the Safety and Efficacy of Nilotinib in Newly Diagnosed Patients with Philadelphia Chromosome Positive (Ph plus ) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) in Taiwan
    Hwang, Wen-Li
    Han, Shao-Min
    Lin, Shyuann-Yuh
    Chang, Ming-Chih
    Bai, Li-Yuan
    Hsiao, Pei-Ching
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Liu, Ta-Chih
    Wang, Po-Nan
    Gau, Jyh-Pyng
    Lee, Yee-Ming
    Ku, Fan-Chen
    Tang, Jih-Luh
    BLOOD, 2018, 132
12345